| Financial Year |
March 31 2023 |
| Monetary Funds |
486,689,123.93 |
| Held-for-trading Financial Assets |
270,000,000.00 |
| Notes Receivable |
50,000.00 |
| Accounts Receivable |
758,776,554.86 |
| Advances to Suppliers |
44,927,737.42 |
| Other Receivables |
11,883,563.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
497,235,556.89 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
53,240,809.50 |
| Total Current Assets |
2,122,803,346.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
10,966,181.42 |
| Investment Properties |
-- |
| Fixed Assetes |
1,028,086,968.70 |
| Under-construction Projects |
98,960,888.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
101,022,967.17 |
| R&D expenses |
-- |
| Goodwill |
617,678,283.00 |
| Long-Term Deferred and Prepaid Expenses |
29,231,832.77 |
| Deferred Income Tax Assets |
22,726,470.60 |
| Other Non-Current Assets |
9,463,227.00 |
| Sub-Total of Non-Current Assets |
2,097,058,872.63 |
| Total Assets |
4,219,862,218.68 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
22,567,052.33 |
| Accounts Payable |
730,657,593.77 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
41,013,321.96 |
| Taxes Payable |
30,111,159.27 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,752,535.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
63,052,404.03 |
| Other Current Liabilities |
33,087,497.68 |
| Sub-Total of Current Liabilities |
1,005,991,550.50 |
| Long-term Loans |
498,085,613.17 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,475,788.57 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
695,561,992.67 |
| Total Liabilities |
1,701,553,543.17 |
| Paid-In Capital(Or Share Stock) |
295,455,913.00 |
| Capital Surplus |
848,405,910.27 |
| Surplus Reserve |
141,756,771.13 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,196,375,066.50 |
| Minority Stockholder's Interest |
32,382,062.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,485,926,612.99 |
| Owner's Equity（Stockholder's Equity） |
2,518,308,675.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,219,862,218.68 |
